Properties
Description
Tezosentan inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets ETA, and ETB.
Molecular Formula
C27H27N9O6S
Targets
ETA: 9.5 (pA2); ETB: 7.7 (pA2)
Applications
Tezosentan can be used for its ability to dilate pulmonary blood vessels and improve blood flow.